Kazia Therapeutics (ADR)
Develops paxalisib and licensed oncology programs for treatment-resistant cancers.
$13.92
After-hours close+0.27 (+2.00%)
At close$13.65(−19.23%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$0.65 | — | — |
| Mar 2026 | −$0.01 | −$0.58 | −8,205.2% |
| Nov 2025 | −$0.01 | −$0.43 | −6,529.9% |
| Jun 2025 | −$0.01 | −$4.18 | −63,968.6% |
| May 2025 | −$10.76 | −$7.61 | +29.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Mar 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Feb 2022 | |||
| Jan 2022 | |||
| Sep 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Aug 2017 | |||
| Feb 2017 | |||
| Aug 2016 | |||
| Feb 2016 | |||
| Aug 2015 | |||
| Feb 2015 | |||
| Oct 2014 | |||
| Feb 2014 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Dec 2011 | |||
| Jun 2011 | |||
| Dec 2010 | |||
| Jun 2010 | |||
| Dec 2009 | |||
| Jun 2009 | |||
| Dec 2008 | |||
| Jun 2008 | |||
| Dec 2007 | |||
| Jun 2007 | |||
| Dec 2006 | |||
| Jun 2006 | |||
| Dec 2005 | |||
| Jun 2005 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | −$0.65 | — | — | $133.5K | — | — |
| Mar 16, 2026 | −$0.01 | −$0.58 | −8,205.2% | — | $216.9K | — |
| Nov 7, 2025 | −$0.01 | −$0.43 | −6,529.9% | $10.5K | $10.5K | +0.3% |
| Jun 30, 2025 | −$0.01 | −$4.18 | −63,968.6% | $10.5K | $12.9K | +23.2% |
| May 28, 2025 | −$10.76 | −$7.61 | +29.3% | — | $13.8K | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 19, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 27, 2023 | ||||||
| Mar 9, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Oct 6, 2022 | ||||||
| Feb 23, 2022 | ||||||
| Jan 6, 2022 | ||||||
| Sep 30, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Aug 30, 2017 | ||||||
| Feb 22, 2017 | ||||||
| Aug 30, 2016 | ||||||
| Feb 22, 2016 | ||||||
| Aug 31, 2015 | ||||||
| Feb 28, 2015 | ||||||
| Oct 3, 2014 | ||||||
| Feb 28, 2014 | ||||||
| Jun 30, 2013 | ||||||
| Dec 31, 2012 | ||||||
| Jun 30, 2012 | ||||||
| Dec 31, 2011 | ||||||
| Jun 30, 2011 | ||||||
| Dec 31, 2010 | ||||||
| Jun 30, 2010 | ||||||
| Dec 31, 2009 | ||||||
| Jun 30, 2009 | ||||||
| Dec 31, 2008 | ||||||
| Jun 30, 2008 | ||||||
| Dec 31, 2007 | ||||||
| Jun 30, 2007 | ||||||
| Dec 31, 2006 | ||||||
| Jun 30, 2006 | ||||||
| Dec 31, 2005 | ||||||
| Jun 30, 2005 | ||||||